
Chemical Leak at West Virginia Plant Kills 2, Injures 19
A chemical reaction at a silver recovery facility in West Virginia resulted in two deaths and 19 hospitalizations.

A chemical reaction at a silver recovery facility in West Virginia resulted in two deaths and 19 hospitalizations.

Scientists report progress on new treatments for hair loss affecting women and ovarian cancer therapies that extend patient survival.

Bangladesh has recorded more than 60,000 suspected measles cases in just over two months, with hundreds of children dying from the disease.

Danish pharmaceutical giant Novo Nordisk has partnered with telehealth company Hims & Hers on weight loss treatment collaboration.

Spanish authorities confirmed another hantavirus case connected to the MV Hondius cruise ship outbreak that killed three people earlier this month.

Recent research examines rising rectal cancer deaths in younger Americans, dementia identification methods, and evolving suicide prevention strategies.

Researchers at Columbia University have created a two-step RNA therapy that could potentially repair cardiovascular tissue damaged by heart attacks.

California officials charged 21 suspects in a hospice fraud scheme that allegedly defrauded the state of $267 million.

Health authorities are expanding access to an injectable immunotherapy that significantly shortens cancer treatment administration time.

Recent research examines health effects of fluoride, kratom poisonings, pregnancy Tylenol use, and anemia's cancer connection.

New research indicates GLP-1 medications may be associated with lower cancer progression rates, findings to be presented at major oncology conference.

Multiple health care issues emerge including cost reform efforts, Alzheimer's testing debates, cancer research, and rural funding concerns.
Biotech company Replimune will resubmit its experimental melanoma treatment for FDA approval following two prior rejections over study design concerns.

Pharmaceutical company Eli Lilly's recently launched obesity medication reached approximately 4,000 prescriptions in its second week on the market.

Democratic think tanks advocate for free primary care while psychiatry reform efforts and FDA personnel changes signal broader healthcare policy shifts.
Page 12 of 42 (620 stories)